TrialAlzheimer's research & therapy2018

A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil.

Terence Fullerton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.